De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D. Shi, William G. Kaelin, Joseph Buehler et al.|Cancer Cell|2022Cited by 132
De Novo Pyrimidine Synthesis is a Targetable Vulnerability in IDH Mutant GliomaDiana D. Shi, Samuel K. McBrayer, Milan R. Savani et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 11
Identification of De Novo Pyrimidine Synthesis as a Targetable Vulnerability in a Novel IDH1 Mutant Engineered Astrocytoma ModelDerek Shi, Samuel K. McBrayer, A.C. Wang et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 2